Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

19 projects found matching your search criteria :

  1. Identification of new genetic risk factors and protein markers affecting susceptibility to non-small cell lung cancer in...

    Call: OPUS 8 , Panel: NZ5

    Principal investigator: prof. Piotr Kuśnierczyk

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda PAN

  2. The role of mTORC1 and mTORC2 complexes in the maintenance of stem-like phenotype of non-small lung adenocarcinoma A549 ...

    Call: PRELUDIUM 6 , Panel: NZ3

    Principal investigator: Marcin Serocki

    Politechnika Gdańska, Wydział Chemiczny

  3. The role of estrogens in epigenetic regulation of hypoxia-related gene expression in non-small cell lung cancer developm...

    Call: OPUS 6 , Panel: NZ5

    Principal investigator: prof. Paweł Jagodziński

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Medyczny

  4. Mechanism regulating vitamin D analog cooperation with cytostatics and tyrosine kinase inhibitors in non-small cell lung...

    Call: PRELUDIUM 5 , Panel: NZ4

    Principal investigator: dr Ewa Maj

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda PAN

  5. Analysis of immunohistochemical and morphological phenotype of poorly differentated non-small cell lung cancer.

    Call: PRELUDIUM 1 , Panel: NZ4

    Principal investigator: Jolanta Szade

    Gdański Uniwersytet Medyczny, Wydział Lekarski z Oddziałem Stomatologicznym

  6. Targeting adenylate kinase 4 (AK4) as a new paradigm in the treatment of non-small cell lung cancer: discovery and evalu...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr Magdalena Wujak

    Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy

  7. Targeting Energy Metabolism for Precision Cancer Therapy: Novel Inhibitors of LDH-A and PDK1 as Potential Strategies to ...

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Marika Frańczak

    Gdański Uniwersytet Medyczny, Wydział Lekarski

  8. New strategies in the treatment of non-small cell lung cancer based on silk nanocarriers targeting tumor vascularization

    Call: SONATA 17 , Panel: NZ7

    Principal investigator: dr Anna Florczak

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  9. RE-SENSE: Dual-loaded lipid nanoparticles to overcome the resistance of non-small cell lung cancer cells to personalized...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Mikołaj Czajkowski

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  10. Comprehensive characterization of tumor immune contexture changes induced by cytotoxic agents in non-small cell lung can...

    Call: PRELUDIUM BIS 2 , Panel: NZ5

    Principal investigator: prof. Wojciech Fendler

    Uniwersytet Medyczny w Łodzi

  11. Usefulness of 'liquid biopsy" in diagnostics, stratification, and monitoring of therapy in non-small cell lung cancer pa...

    Call: PRELUDIUM BIS 2 , Panel: NZ5

    Principal investigator: dr hab. Joanna Budna-Tukan

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Medyczny

  12. The immune checkpoints in non-small cell lung cancer - research on genetic and epigenetic mechanism regulating mRNA and ...

    Call: OPUS 17 , Panel: NZ5

    Principal investigator: dr hab. Monika Jasek

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  13. Identyfication of the epigenetic modulation mechanisms of SOX genes and their transcripts as a potential diagnostic mark...

    Call: OPUS 16 , Panel: NZ5

    Principal investigator: prof. Piotr Dzięgiel

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Lekarski

  14. Molecular profile of exosomes present in bronchoalveolar lavage fluid as novel biomarker of immune dysfunction in non-sm...

    Call: OPUS 14 , Panel: NZ6

    Principal investigator: dr Małgorzata Czystowska-Kuźmicz

    Warszawski Uniwersytet Medyczny, Wydział Lekarski

  15. The effect of SATB1 on the EGFR level and the progression of non-small cell lung cancers

    Call: PRELUDIUM 13 , Panel: NZ5

    Principal investigator: Natalia Glatzel-Plucińska

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Lekarski

  16. The forced oscillation technique in patients with non-small cell lung cancer after thoracic surgery subjected to an earl...

    Call: PRELUDIUM 12 , Panel: NZ7

    Principal investigator: dr Sabina Kostorz-Nosal

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Medycznych w Zabrzu

  17. Molecular background of brain metastases in lung cancer

    Call: SONATA 12 , Panel: NZ2

    Principal investigator: dr Marcin Nicoś

    Uniwersytet Medyczny w Lublinie, Wydział Lekarski

  18. The Role of Tesmin Expression in Non-small Cell Lung Cancer

    Call: PRELUDIUM 12 , Panel: NZ5

    Principal investigator: Jędrzej Grzegrzółka

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Lekarski

  19. Analysis of the effectiveness of anticancer activity of tyrosine kinase inhibitors combined with nanoparticles in in vit...

    Call: SONATA 11 , Panel: ST4

    Principal investigator: dr Natalia Piergies

    Instytut Fizyki Jądrowej im. Henryka Niewodniczańskiego Polskiej Akademii Nauk